
CAS 1133229-30-7
:Formula:C8H14N2O2
InChI:InChI=1S/C8H14N2O2/c1-2-6(8(9)12)10-5-3-4-7(10)11/h6H,2-5H2,1H3,(H2,9,12)/t6-/m0/s1/i3D2,4D2,5D2
InChI key:HPHUVLMMVZITSG-QXMLZOKMSA-N
SMILES:[2H]C1(C(=O)N(C(C1([2H])[2H])([2H])[2H])[C@@H](CC)C(=O)N)[2H]
Filter by
Purity percentage
0
100
|
0
|
50
|
90
|
95
|
100
Found 5 products.
- Lower prices
- Higher prices
- Lower purities
- Higher purities
- Faster estimated delivery
Levetiracetam-d6
CAS:Formula:C8H8D6N2O2Color and Shape:White To Off-White SolidMolecular weight:176.25Levetiracetam-d6
CAS:Controlled ProductApplications Levetiracetam-d6 is a labelled (S)-enantiomer of the ethyl analog of Piracetam (P500800), an anticonvulsant.
References Gower, A.J., et al.: Eur. J. Pharmacol., 222, 193 (1992), Kasteleijn-Noist Trenite, D.G.A., et al.: Epilepsy Res., 25, 225 (1996), Patsalos, P.N., et al.: Pharmacol. Ther., 85, 77 (2000),Formula:C8D6H8N2O2Color and Shape:NeatMolecular weight:176.25Levetiracetam-d6
CAS:Controlled ProductLevetiracetam-d6 is a metabolite of levetiracetam, which is an antiepileptic drug. Levetiracetam-d6 is used as a marker for the determination of plasma concentrations and bioequivalence of levetiracetam. It is also used to study the pharmacokinetics of levetiracetam in healthy Chinese subjects. The plasma concentration-time profile and terminal half-life of levetiracetam and its major metabolite, levetiracetam-d6, were determined from serial blood samples taken from healthy Chinese volunteers following a single oral dose of 1000 mg (2000 mg) levetiracetam. The pharmacokinetic parameters were calculated using noncompartmental analysis with WinNonlin software (Pharsight Corporation). The mean ± SD Cmax and Tmax values for the two substances were 1220 ± 607 ng/mL and 0.5 ± 1 hour, respectively, forFormula:C8H14N2O2Purity:Min. 95%Molecular weight:176.25 g/mol





